Last updated on January 2019

Driving Reduced AIDS-associated Meningo-encephalitis Mortality


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Meningoencephalitis | Cryptococcal meningitis | AIDS-Related Opportunistic Infections
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Consecutive patients > 18 years with 1st episode of suspected meningo- encephalitis
  2. Known to be HIV positive or willing to undertake an HIV test
  3. Willing to agree to participate in the study

Exclusion Criteria:

  1. Patients presenting with suspected relapse of HIV-associated meningo-encephalitis
  2. Cerebral malaria confirmed on point of care test or thick/thin blood film, by clinical evaluation and further investigation, as required
  3. HIV negative patients
  4. Pregnant or lactating patients

Patients who are HIV negative or are diagnosed with cerebral malaria on hospital admission or after initial investigation will be excluded or withdrawn from the DREAMM study.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.